80
Views
7
CrossRef citations to date
0
Altmetric
Original Article

The dual treatment of acne vulgaris using two kinds of ELOSTM (electro optical synergy) system: A simultaneous split‐face trial

Pages 213-216 | Received 04 Mar 2008, Accepted 20 Mar 2008, Published online: 12 Jul 2009
 

Abstract

Background: RF‐pulsed light with ELOS technology devices have recently been used to treat acne vulgaris in selected patients. Objective: To investigate the safety and efficacy of a combination of two kinds of device with ELOS technology for the treatment of acne. Methods: Ten patients with moderate acne were treated twice weekly for 4 weeks with the Aurora AC® (Syneron Medical Ltd, Yokneam, Israel), a combination of pulsed light and RF energy. Immediately after Aurora AC treatment, all patients were treated weekly only on one facial half with the Matrix IR® (Syneron Medical Ltd), a combination of fractional diode laser and RF energy. Photographic documentations were obtained at baseline, before each treatment session, and 1 and 3 months after the final treatment. Results: At 3 months after treatment, the mean lesion count was reduced by 38% (p<0.05) after eight treatments with the Aurora AC alone. With additional treatment with the Matrix IR, the mean lesion count was reduced by 61%. Conclusion: The combination of Aurora AC and Matrix IR was superior in reducing the acne lesion count, and in extending the length of the remission period.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.